ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
16.17
-0.44 (-2.65%)
Dec 3, 2024, 12:32 PM EST - Market open
ACADIA Pharmaceuticals Employees
As of December 31, 2023, ACADIA Pharmaceuticals had 598 total employees, including 597 full-time and 1 part-time employees. The number of employees increased by 85 or 16.57% compared to the previous year.
Employees
598
Change (1Y)
85
Growth (1Y)
16.57%
Revenue / Employee
$1,553,906
Profits / Employee
$214,893
Market Cap
2.69B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
Concentra Group Holdings Parent | 9,020 |
QuidelOrtho | 7,100 |
Warby Parker | 3,473 |
Zai Lab | 2,175 |
iRhythm Technologies | 2,000 |
Privia Health Group | 1,102 |
Catalyst Pharmaceuticals | 167 |
ACAD News
- 5 days ago - Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET - Seeking Alpha
- 6 days ago - Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711 - Business Wire
- 11 days ago - Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences - Business Wire
- 17 days ago - Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 22 days ago - Acadia Pharmaceuticals: Proving The Naysayers Wrong - Seeking Alpha
- 26 days ago - ACADIA Pharmaceuticals Inc. (ACAD) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 26 days ago - Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview - Business Wire
- 27 days ago - Acadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million - Business Wire